Search

You searched for "modelling"

1108 results found

Mr Lego shows that visual impairment doesn't have to hold you back

3 September 2026 | charity, patient stories
Stewart Lamb Cromar, from Edinburgh, has achieved a lifelong ambition after Lego turned one of his designs into an official set. It is a goal he has been working towards for more than a decade, and one he feared might...

From spine to eye: The benefits of multidisciplinary research

10 April 2025 | | EYE - Glaucoma, EYE - Neuro-ophthalmology
What have spinal and vision research got in common? More than you’d think. Dr Richard Eva. Funded by Fight for Sight, Dr Richard Eva came to vision from spinal cord research and is now co-lead on a project related to...

Refraction planning in cataract: avoid creating an unhappy patient

1 June 2017 | | EYE - Cataract, EYE - Refractive
“It is much more important to know what sort of a patient has a disease than what sort of a disease a patient has.” William Osler The focus of this paper is the prevention of an unhappy patient following cataract...

Crystalline keratopathy in monoclonal gammopathy of undetermined significance

2 April 2025 | | EYE - Cornea
Monoclonal gammopathies encompass a group of plasma cell disorders characterised by the excessive production of abnormal monoclonal immunoglobulins in the bloodstream [1]. This category includes multiple myeloma, monoclonal gammopathy of undetermined significance (MGUS), amyloidosis and other lymphoproliferative disorders. Monoclonal gammopathy...

Ocular electrophysiology

1 April 2014 | | EYE - Oculoplastic, EYE - Orbit
A 34-year-old woman, who is a CEO in a multinational firm, has been losing vision over the last 12 months. She has seen her opticians, who initially tried different glasses but could not improve things. Clinical examination is unremarkable. How...

Intravitreal injections delivered by ophthalmic clinical nurse specialists

1 June 2015 | | EYE - Vitreo-Retinal
Intravitreal injections of the anti-vascular endothelial growth factor (anti-VEGF) agent ranibizumab, for the treatment of wet age-related macular degeneration (AMD) was approved by National Institute for Health & Care Excellence (NICE) in 2008 [1]. The Manchester Royal Eye Hospital (MREH),...

Rb-NET: a network to save life and preserve vision in children in Africa

1 April 2018 | | EYE - Pathology, EYE - Oncology
Responding to need is a key element underpinning the VISION 2020 LINKS Programme [1]. It is embedded in the process through which LINKS are established, with institutions in low- and middle-income countries (LMICs) first defining their priority areas of training...

How effective is nurse-led telephone preassessment for cataract surgery?

25 July 2023 | | EYE - Cataract, EYE - Refractive
Cataract surgery is the most frequently performed surgical procedure in the UK [1]. The demand for cataract surgery is projected to increase with ageing population, and the recent pandemic has further contributed to the extended waiting times in the UK....

RNIB puts vital eyecare support in place across Hertfordshire and West Essex

24 September 2025 | charity, ECLO, patient stories, RNIB
Patients with eye conditions across Hertfordshire and West Essex now have access to vital emotional and practical support as The Royal National Institute of Blind People (RNIB) has employed three specialist officers at hospital eye clinics across the region. The...

Neurofibromatosis type 2 – diagnosis, features and MDT approach

1 December 2021 | | EYE - Orbit, EYE - Vitreo-Retinal, EYE - Cataract, EYE - Refractive, EYE - General
NF2 is a genetic condition caused by mutation in a single gene (NF2 gene) on chromosome 22. The NF2 gene provides instructions to produce a protein called merlin, also known as schwannomin. This protein functions as a tumour suppressor, preventing...

Surgical strategies to manage incomitant strabismus in adults

5 April 2022 | | EYE - Paediatrics, EYE - Strabismus, EYE - General
Incomitant vertical and / or horizontal strabismus is a challenging presentation. Patients are usually symptomatic as the onset is either sudden so they haven’t developed any coping mechanisms or very complex so that any coping mechanisms will not cover all...

A unique case of macular burn from ‘toy’ laser

2 February 2024 | | EYE - General
The first laser was created in 1960 and its name is an acronym for ‘light amplification by stimulated emission of radiation’. Laser technology has been used for medical, industrial, research and entertainment purposes in a variety of fields following extensive...